Advanced search
Publication Cover
Renal Failure Volume 40, 2018 - Issue 1
Submit an article Journal homepage
1,838
Views
13
CrossRef citations to date
0
Altmetric
Clinical Study

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy

Pei ChenDepartment of Medicine, Renal Division, Peking University First Hospital, Beijing, China; ;Peking University Institute of Nephrology, Beijing, China; ;Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; ;Ministry of Education, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Beijing, ChinaView further author information
,
Su-Fang ShiDepartment of Medicine, Renal Division, Peking University First Hospital, Beijing, China; ;Peking University Institute of Nephrology, Beijing, China; ;Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; ;Ministry of Education, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Beijing, ChinaView further author information
,
Zhen QuDepartment of Medicine, Renal Division, Peking University First Hospital, Beijing, China; ;Peking University Institute of Nephrology, Beijing, China; ;Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; ;Ministry of Education, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Beijing, ChinaView further author information
,
Na ZhaoDepartment of Medicine, Renal Division, Peking University First Hospital, Beijing, China; ;Peking University Institute of Nephrology, Beijing, China; ;Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; ;Ministry of Education, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Beijing, ChinaView further author information
,
Xin-Fang XieDepartment of Medicine, Renal Division, Peking University First Hospital, Beijing, China; ;Peking University Institute of Nephrology, Beijing, China; ;Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; ;Ministry of Education, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Beijing, ChinaView further author information
,
Ji-Cheng LvDepartment of Medicine, Renal Division, Peking University First Hospital, Beijing, China; ;Peking University Institute of Nephrology, Beijing, China; ;Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; ;Ministry of Education, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Beijing, ChinaView further author information
,
Li-Jun LiuDepartment of Medicine, Renal Division, Peking University First Hospital, Beijing, China; ;Peking University Institute of Nephrology, Beijing, China; ;Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; ;Ministry of Education, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Beijing, ChinaCorrespondence[email protected]
View further author information
&
Hong ZhangDepartment of Medicine, Renal Division, Peking University First Hospital, Beijing, China; ;Peking University Institute of Nephrology, Beijing, China; ;Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; ;Ministry of Education, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Beijing, ChinaView further author information
 show all
Pages 213-218 | Received 19 Aug 2017, Accepted 15 Mar 2018, Published online: 05 Apr 2018

References

  • Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis. 1988;12:340–347.
  • Coppo R, Troyanov S, Bellur S, et al. Validation of the Oxford Classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86:828–836.
  • Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol. 2004;24:197–217.
  • Suzuki K, Honda K, Tanabe K, et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int. 2003;63:2286–2294.
  • Suzuki H, Moldoveanu Z, Hall S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 2008;118:629–639.
  • Zhao N, Hou P, Lv J, et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int. 2012;82:790–796.
  • Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21.
  • Hoxha E, Kneissler U, Stege G, et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012;82:797–804.
  • Doi T, Kanatsu K, Nagai H, et al. An overlapping syndrome of IgA nephropathy and membranous nephropathy? Nephron. 1983;35:24–30.
  • Frasca GM, Soverini L, Preda P, et al. Two different glomerular diseases in the same patient at an interval of 7 years. Nephrol Dialysis Transplant. 2002;17:2014–2016.
  • Jennette JC, Newman WJ, Diaz-Buxo JA. Overlapping IgA and membranous nephropathy. Am J Clin Pathol. 1987;88:74–78.
  • Kobayashi Y, Fujii K, Hiki Y, et al. Coexistence of IgA nephropathy and membranous nephropathy. Acta Pathol Japon. 1985;35:1293–1299.
  • Lai KN, Lai FM, Lo ST, et al. IgA nephropathy and membranous nephropathy associated with hepatitis B surface antigenemia. Hum Pathol. 1987;18:411–414.
  • Magil A, Webber D, Chan V. Glomerulonephritis associated with hepatitis B surface antigenemia. Report of a case with features of both membranous and IgA nephropathy. Nephron. 1986;42:335–339.
  • Miyazaki K, Miyazaki M, Tsurutani H, et al. Development of IgA nephropathy 14 years after diagnosis of membranous nephropathy. Nephrol Dialysis Transplant. 2002;17:140–143.
  • Monga G, Mazzucco G, di Belgiojoso GB, et al. Pattern of double glomerulopathies: a clinicopathologic study of superimposed glomerulonephritis on diabetic glomerulosclerosis. Mod Pathol. 1989;2:407–414.
  • Stokes MB, Alpers CE. Combined membranous nephropathy and IgA nephropathy. Am J Kidney Dis. 1998;32:649–656.
  • Kong X, Ma Y, Chen J, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dialysis Transplant. 2013;28:641–651.
  • Working Group of the International Ig ANN, the Renal Pathology S, Roberts IS, et al. The Oxford Classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76:546–556.
  • Trimarchi H, Barratt J, Cattran DC, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91:1014–1021.
  • Hoxha E, Harendza S, Zahner G, et al. An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dialysis Transplant. 2011;26:2526–2532.
  • Lv J, Hou W, Zhou X, et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol. 2013;24:1323–1329.
  • Hoxha E, Harendza S, Zahner G, et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dialysis Transplant. 2011;26:2526–2532.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.